Announced
Completed
Synopsis
Andreessen Horowitz led a $100m Series A round in Dyno Therapeutics, a biotechnology company applying artificial intelligence to gene therapy, with participation from Casdin Capital, GV, Obvious Ventures, Lux Capital, Polaris Partners, CRV and KdT Ventures. "This Series A financing accelerates our AI-powered discovery of best-in-class capsids targeting all major organs and cell types, enabling Dyno to grow our business infrastructure and establish more partnerships to become the premier developer of gene therapy vectors," Eric Kelsic, Dyno Therapeutics Founder and CEO.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.